News
Datroway approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast...
Datroway (datopotamab deruxtecan or Dato-DXd) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative...
Cancer Research UK, Cytovation and the Norwegian Cancer Society to advance rare cancer treatment
Cancer Research UK, Cytovation and the Norwegian Cancer Society have signed an agreement to bring Cytovation’s lead asset, CY-101, into a multi-national Phase 2...
Multi-million Euro research initiative to use biomarkers to transform Crohn’s Disease
In a groundbreaking effort to change the future of Crohn’s Disease, the INTERCEPT project has launched Europe’s first-ever trial using biomarkers aimed at preventing...
